Harrington J M, Goldblatt P
Br J Ind Med. 1986 Mar;43(3):206-11. doi: 10.1136/oem.43.3.206.
This study was designed to investigate whether the mortality of British pharmaceutical industry workers showed any evidence of occupationally related patterns associated with particular sections of the industry with special emphasis on cancers and respiratory diseases. The data were extracted from census schedules by the Office of Population Censuses and Surveys using occupational categories recorded by pharmaceutical workers at the 1961 and 1971 censuses of England and Wales. Subsequent mortality was ascertained through the National Health Service Central Registry. Both cohorts, followed up to the end of 1981, showed a "healthy worker effect," with overall SMRs ranging from 0.77 to 1.04, though comparison with the employed populations of the longitudinal study reduced this effect by 25%. Evidence of inconsistent excess mortality was noted in small numbers for suicide (SMR 0.91 to 2.79) and cancer of the large intestine (SMR 1.09 to 2.38). There was no clear association between the type of industry and the causes of death investigated. Although the census based study has several methodological shortcomings, there was no evidence, on the basis of this study, to suggest any excess mortality risk from employment in the pharmaceutical industry.
本研究旨在调查英国制药行业工人的死亡率是否显示出与该行业特定部门相关的职业关联模式,特别关注癌症和呼吸系统疾病。数据由人口普查与调查办公室从普查表中提取,使用的是制药工人在1961年和1971年英格兰和威尔士人口普查中记录的职业类别。随后的死亡率通过国民保健服务中央登记处确定。两个队列随访至1981年底,均显示出“健康工人效应”,总体标准化死亡比(SMR)在0.77至1.04之间,不过与纵向研究中的就业人群相比,这种效应降低了25%。少量的自杀(SMR为0.91至2.79)和大肠癌症(SMR为1.09至2.38)存在不一致的超额死亡率证据。行业类型与所调查的死亡原因之间没有明确关联。尽管基于普查的研究存在若干方法学缺陷,但基于本研究,没有证据表明从事制药行业会带来任何超额死亡风险。